本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Theravance Biopharma Inc.

16.78
+0.14000.84%
盤後17.230.4527+2.70%18:29 EDT
成交量:52.68萬
成交額:873.70萬
市值:8.64億
市盈率:8.15
高:16.80
開:16.58
低:16.36
收:16.64
52周最高:21.03
52周最低:8.33
股本:5,149.29萬
流通股本:2,184.42萬
量比:1.48
換手率:2.41%
股息:- -
股息率:- -
每股收益(TTM):2.06
每股收益(LYR):2.06
淨資產收益率:44.85%
總資產收益率:-0.54%
市淨率:2.91
市盈率(LYR):8.15

資料載入中...

2022/08/05

SEC問詢函

CORRESP [Cover] - Correspondence
2022/08/04

重要事件披露

8-K - Current report
2022/08/03

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/07/20

重要事件披露

8-K - Current report
2022/07/14

重要事件披露

8-K - Current report
2022/07/13

重要事件披露

8-K - Current report
2022/06/16

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/05/06

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/05/05

重要事件披露

8-K - Current report
2022/04/28

重要事件披露

8-K - Current report
2022/04/21

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/04/04

重要事件披露

8-K - Current report
2022/03/04

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2022/02/28

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2022/02/23

重要事件披露

8-K - Current report
2022/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/11

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/11

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/10

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals